These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

698 related articles for article (PubMed ID: 30150001)

  • 1. Metformin as an Anticancer Agent.
    Vancura A; Bu P; Bhagwat M; Zeng J; Vancurova I
    Trends Pharmacol Sci; 2018 Oct; 39(10):867-878. PubMed ID: 30150001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin and Breast Cancer: Molecular Targets.
    Faria J; Negalha G; Azevedo A; Martel F
    J Mammary Gland Biol Neoplasia; 2019 Jun; 24(2):111-123. PubMed ID: 30903363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin-induced inhibition of the mitochondrial respiratory chain increases FGF21 expression via ATF4 activation.
    Kim KH; Jeong YT; Kim SH; Jung HS; Park KS; Lee HY; Lee MS
    Biochem Biophys Res Commun; 2013 Oct; 440(1):76-81. PubMed ID: 24041694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial targets of metformin-Are they physiologically relevant?
    Pecinová A; Brázdová A; Drahota Z; Houštěk J; Mráček T
    Biofactors; 2019 Sep; 45(5):703-711. PubMed ID: 31343786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus.
    Foretz M; Guigas B; Viollet B
    Nat Rev Endocrinol; 2019 Oct; 15(10):569-589. PubMed ID: 31439934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AMPK regulation of Raptor and TSC2 mediate metformin effects on transcriptional control of anabolism and inflammation.
    Van Nostrand JL; Hellberg K; Luo EC; Van Nostrand EL; Dayn A; Yu J; Shokhirev MN; Dayn Y; Yeo GW; Shaw RJ
    Genes Dev; 2020 Oct; 34(19-20):1330-1344. PubMed ID: 32912901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular targets of metformin antitumor action.
    Sośnicki S; Kapral M; Węglarz L
    Pharmacol Rep; 2016 Oct; 68(5):918-25. PubMed ID: 27362768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular action of metformin in hepatocytes: an updated insight.
    Sliwinska A; Drzewoski J
    Curr Diabetes Rev; 2015; 11(3):175-81. PubMed ID: 25808533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin in cancer.
    Mallik R; Chowdhury TA
    Diabetes Res Clin Pract; 2018 Sep; 143():409-419. PubMed ID: 29807101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-diabetic drug metformin: challenges and perspectives for cancer therapy.
    Snima KS; Pillai P; Cherian AM; Nair SV; Lakshmanan VK
    Curr Cancer Drug Targets; 2014; 14(8):727-36. PubMed ID: 25329671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticancer effects of metformin and its potential use as a therapeutic agent for breast cancer.
    Guppy A; Jamal-Hanjani M; Pickering L
    Future Oncol; 2011 Jun; 7(6):727-36. PubMed ID: 21675836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Insight into the Effects of Metformin on Diabetic Retinopathy, Aging and Cancer: Nonapoptotic Cell Death, Immunosuppression, and Effects beyond the AMPK Pathway.
    Hsu SK; Cheng KC; Mgbeahuruike MO; Lin YH; Wu CY; Wang HD; Yen CH; Chiu CC; Sheu SJ
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin: from mechanisms of action to therapies.
    Foretz M; Guigas B; Bertrand L; Pollak M; Viollet B
    Cell Metab; 2014 Dec; 20(6):953-66. PubMed ID: 25456737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin, cancer and glucose metabolism.
    Salani B; Del Rio A; Marini C; Sambuceti G; Cordera R; Maggi D
    Endocr Relat Cancer; 2014; 21(6):R461-71. PubMed ID: 25273809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin inhibition of mTORC1 activation, DNA synthesis and proliferation in pancreatic cancer cells: dependence on glucose concentration and role of AMPK.
    Sinnett-Smith J; Kisfalvi K; Kui R; Rozengurt E
    Biochem Biophys Res Commun; 2013 Jan; 430(1):352-7. PubMed ID: 23159620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin induces autophagy and G0/G1 phase cell cycle arrest in myeloma by targeting the AMPK/mTORC1 and mTORC2 pathways.
    Wang Y; Xu W; Yan Z; Zhao W; Mi J; Li J; Yan H
    J Exp Clin Cancer Res; 2018 Mar; 37(1):63. PubMed ID: 29554968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An update on mode of action of metformin in modulation of meta-inflammation and inflammaging.
    Khodadadi M; Jafari-Gharabaghlou D; Zarghami N
    Pharmacol Rep; 2022 Apr; 74(2):310-322. PubMed ID: 35067907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic switching in the hypoglycemic and antitumor effects of metformin on high glucose induced HepG2 cells.
    Lv Y; Tian N; Wang J; Yang M; Kong L
    J Pharm Biomed Anal; 2018 Jul; 156():153-162. PubMed ID: 29705631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin Antagonizes Cancer Cell Proliferation by Suppressing Mitochondrial-Dependent Biosynthesis.
    Griss T; Vincent EE; Egnatchik R; Chen J; Ma EH; Faubert B; Viollet B; DeBerardinis RJ; Jones RG
    PLoS Biol; 2015 Dec; 13(12):e1002309. PubMed ID: 26625127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin suppresses glucose-6-phosphatase expression by a complex I inhibition and AMPK activation-independent mechanism.
    Ota S; Horigome K; Ishii T; Nakai M; Hayashi K; Kawamura T; Kishino A; Taiji M; Kimura T
    Biochem Biophys Res Commun; 2009 Oct; 388(2):311-6. PubMed ID: 19664596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.